[go: up one dir, main page]

IT1401461B1 - USE OF SELECTED POLYSATURATED FATTY ACIDS FOR THE TREATMENT OF DIASTOLIC HEART RATE. - Google Patents

USE OF SELECTED POLYSATURATED FATTY ACIDS FOR THE TREATMENT OF DIASTOLIC HEART RATE.

Info

Publication number
IT1401461B1
IT1401461B1 ITMI2010A001070A ITMI20101070A IT1401461B1 IT 1401461 B1 IT1401461 B1 IT 1401461B1 IT MI2010A001070 A ITMI2010A001070 A IT MI2010A001070A IT MI20101070 A ITMI20101070 A IT MI20101070A IT 1401461 B1 IT1401461 B1 IT 1401461B1
Authority
IT
Italy
Prior art keywords
treatment
fatty acids
heart rate
diastolic heart
polysaturated fatty
Prior art date
Application number
ITMI2010A001070A
Other languages
Italian (it)
Inventor
Tiberio Bruzzese
Original Assignee
Bruzzese
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bruzzese filed Critical Bruzzese
Priority to ITMI2010A001070A priority Critical patent/IT1401461B1/en
Publication of ITMI20101070A1 publication Critical patent/ITMI20101070A1/en
Application granted granted Critical
Publication of IT1401461B1 publication Critical patent/IT1401461B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Beans For Foods Or Fodder (AREA)
  • Soy Sauces And Products Related Thereto (AREA)
  • Fertilizers (AREA)
ITMI2010A001070A 2010-06-14 2010-06-14 USE OF SELECTED POLYSATURATED FATTY ACIDS FOR THE TREATMENT OF DIASTOLIC HEART RATE. IT1401461B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITMI2010A001070A IT1401461B1 (en) 2010-06-14 2010-06-14 USE OF SELECTED POLYSATURATED FATTY ACIDS FOR THE TREATMENT OF DIASTOLIC HEART RATE.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2010A001070A IT1401461B1 (en) 2010-06-14 2010-06-14 USE OF SELECTED POLYSATURATED FATTY ACIDS FOR THE TREATMENT OF DIASTOLIC HEART RATE.

Publications (2)

Publication Number Publication Date
ITMI20101070A1 ITMI20101070A1 (en) 2011-12-15
IT1401461B1 true IT1401461B1 (en) 2013-07-26

Family

ID=43413808

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2010A001070A IT1401461B1 (en) 2010-06-14 2010-06-14 USE OF SELECTED POLYSATURATED FATTY ACIDS FOR THE TREATMENT OF DIASTOLIC HEART RATE.

Country Status (1)

Country Link
IT (1) IT1401461B1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010241571B2 (en) * 2009-04-29 2014-06-26 Amarin Pharmaceuticals Ireland Limited Stable pharmaceutical composition and methods of using same

Also Published As

Publication number Publication date
ITMI20101070A1 (en) 2011-12-15

Similar Documents

Publication Publication Date Title
LTPA2020510I1 (en) Substituted 4-phenyl-pyridines for the treatment of NK-receptor related diseases
LT2596786T (en) USE OF EIKOZAPENTAENIC ACID ETHYL ESTER FOR THE TREATMENT OF HYPERTRIGLYCIDEMIA
DK2504005T3 (en) USE OF 1,3-DIPHENYLPROP-2-ONE-1-DERIVATIVES FOR THE TREATMENT OF LIVER DISEASES
SMT201400008B (en) Use of bethanecol for the treatment of xerostomia
EP2539707A4 (en) ARTIFICIAL MEMBRANES OF MYCOLIC ACIDS
PL2766361T3 (en) 8-carbamoyl-2- (2,3-disubstituted pyrid-6-yl) -1,2,3,4, -tetrahydroisoquinoline derivatives as apoptosis inducing agents for the treatment of cancer as well as immunization and autoimmune diseases
RU2557654C3 (en) THERAPEUTIC AGENTS TO REDUCE THE LEVEL OF PARATYROID HORMONE
BR112014028413A2 (en) therapeutic uses of fibroblast growth factor proteins 21.
EP2830478A4 (en) IRRIGATION OF AN INTEGRATED ENDOSCOPE
EP2585084A4 (en) MICRONIZED COMPOSITIONS OF PLACENTAL TISSUE, AND METHODS OF MAKING AND USING THE SAME
HRP20170961T1 (en) PROCEDURE FOR THE PREPARATION OF CARBAMOILPYRIDONE DERIVATIVES AND INTERMEDIATES
SMT201700021B (en) METHODS FOR THE TREATMENT OF AUTOIMMUNE DISEASES WITH ANTAGONISTS OF THE DLL4
PL2717692T3 (en) TETRAHYDROCANNABINOL-11-OWE ACIDS FOR USE IN THE TREATMENT OF FIBERATAL DISEASES
EP2828289A4 (en) GROWTH DIFFERENTIATION FACTOR (GDF) FOR THE TREATMENT OF DIASTOLIC CARDIAC INSUFFICIENCY
HUE038785T2 (en) Traditional Chinese medicine for the treatment of cardiovascular diseases
PL2582366T3 (en) Pharmaceutical combination for the treatment of pain
IT1400545B1 (en) PROCEDURE FOR THE PREPARATION OF BIOLOGICAL FABRIC FOR BIOLOGICAL PROSTHESIS.
PL2613798T3 (en) The use of lysosomal acid lipase for the treatment of patients with lysosomal acid lipase
IL225773B (en) Discovery of the activation time of the heart
EP2743348A4 (en) NEW ANTI-NGF HUMAN ANTIBODIES
SMT201600189B (en) AQUEOUS SOLUTION INCLUDING 3-KINUCLIDINONS FOR THE TREATMENT OF HYPERPROLIFERATIVE, AUTOIMMUNE AND CARDIAC DISEASES
PL2718434T3 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARDIOUS DISEASE
EP2532652A4 (en) THERAPEUTIC AGENT OF HEPATITIS C
IT1403842B1 (en) PROCEDURE FOR THE TREATMENT AND WINEMAKING OF GRAPES
EE201300004A (en) A combined pharmaceutical composition for the treatment of diseases or conditions of the cardiovascular system